Arcutis Biotherapeutics, Inc. (ARQT) Profit Margin
Arcutis Biotherapeutics, Inc. (ARQT) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | -8449.76% |
| 2023-12-31 | -898.17% |
| 2024-12-31 | -84.09% |
| 2025-12-31 | -4.34% |
How ARQT compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| RDNT | RadNet Inc. | -0.91% |
| AKBA | Akebia Therapeutics Inc. | -2.26% |
| INNV | InnovAge Holding Corp. | -3.55% |
| CERS | Cerus Corporation | -6.68% |
| RMTI | Rockwell Medical Inc. | -7.67% |
These are five companies in the same sector as ARQT with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Arcutis Biotherapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("ARQT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ARQT | $26.07 | -1.47% | 0.04M |
| 3 | ||||
| 4 | ||||
| 5 |